GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (ASX:RAC) » Definitions » FCF Yield %

Race Oncology (ASX:RAC) FCF Yield % : -0.50 (As of Apr. 18, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Race Oncology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Race Oncology's Trailing 12-Month Free Cash Flow is A$-0.82 Mil, and Market Cap is A$160.69 Mil. Therefore, Race Oncology's FCF Yield % for today is -0.50%.

The historical rank and industry rank for Race Oncology's FCF Yield % or its related term are showing as below:

ASX:RAC' s FCF Yield % Range Over the Past 10 Years
Min: -0.5   Med: 0   Max: 0
Current: -0.5


ASX:RAC's FCF Yield % is ranked better than
82.91% of 1498 companies
in the Biotechnology industry
Industry Median: -15.565 vs ASX:RAC: -0.50

Race Oncology's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Race Oncology FCF Yield % Historical Data

The historical data trend for Race Oncology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Race Oncology FCF Yield % Chart

Race Oncology Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -3.02 -0.89 -2.01 -5.33 -3.07

Race Oncology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.62 -4.79 -11.88 -0.90 0.49

Competitive Comparison of Race Oncology's FCF Yield %

For the Biotechnology subindustry, Race Oncology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Race Oncology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Race Oncology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Race Oncology's FCF Yield % falls into.


;
;

Race Oncology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Race Oncology's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-9.546 / 310.8048
=-3.07%

Race Oncology's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.571 * 2 / 234.51255
=0.49%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Race Oncology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Race Oncology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Race Oncology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Race Oncology Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000
Race Oncology Ltd is a clinical stage biopharmaceutical company with a mission to be at the heart of cancer care. Its asset, bisantrene, is a small molecule chemotherapeutic. Bisantrene has a clinical history with demonstrated therapeutic benefits in both adult and pediatric patients, a well-characterized safety profile, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. It has reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations, where Race can deliver cardioprotection and enhanced anticancer activity in solid tumors.

Race Oncology Headlines

No Headlines